Of the patients, 73.2% underwent genetic testing, and 30% of them presented germline likely pathogenic or pathogenic variants in cancer predisposition genes (24 BRCA1, 4 BRCA2, 1 PALB2, 1 NBN, and 1 ATM). The gene discussed is PALB2; the disease is cancer.